Genor Biopharma Competitors and Similar CompaniesClear all
Genor Biopharma's competitors and similar companies include Roivant Sciences, Taiwan Liposome, Disc Medicine and Innovent Biologics.
 Genor Biopharma Genor Biopharma is a company that manufactures antibodies and related biological products. |  Taiwan Liposome Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). |  Disc Medicine Disc Medicine (formerly known as Gemini Therapeutics) is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for patients suffering from hematologic diseases.
|  Innovent Biologics Innovent Biologics is a biopharmaceutical company developing and manufacturing monoclonal antibodies. | ||
Founding Date | Founding Date 2007 | Founding Date 2014 | Founding Date 1997 | Founding Date 2017 | Founding Date 2011 |
Type | Type Private | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations CN HQ | Locations London, GB HQ Basel, CH Boston, US New York, US | Locations Taipei, TW HQ 港区, JP Leiden, NL South San Francisco, US | Locations Watertown, US HQ | Locations Fangshan Qu, CN HQ |
Employees | Employees 22245% decrease | Employees 908 | Employees 1652% decrease | Employees 15585% increase | Employees 831 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 8.8 b | Valuation ($) N/A | Valuation ($) 1.4 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $8.3m (FY, 2025) | Revenue (est.) NT$101.9m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($397.9m) (FY, 2025) | Net income (NT$983.3m) (FY, 2020) | Net income ($212.2m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 160m (almost 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 150m (about 8 years ago) |
Total funding raised | Total funding raised $ 212m | Total funding raised $ 1.9b | Total funding raised N/A | Total funding raised $ 50m | Total funding raised $ 560m |
For sources of this data, please see the company profile
View Company Profiles
Roivant Sciences
HQ
London, GB
Employees
908
Roivant Sciences is a company that develops and commercializes medicines.
View companyTaiwan Liposome
HQ
Taipei, TW
Employees
165↓ 2% decrease
Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).
View companyDisc Medicine
HQ
Watertown, US
Employees
155
Disc Medicine (formerly known as Gemini Therapeutics) is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for patients suffering from hematologic diseases.
View companyInnovent Biologics
HQ
Fangshan Qu, CN
Employees
831
Innovent Biologics is a biopharmaceutical company developing and manufacturing monoclonal antibodies.
View company